Showing results (191-200 of 4,035) with videos related to

Sort By:
Pageof 404
Plos Medicine|May 24, 2021
SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trialJohn Kinuthia, Keshet Ronen, Jennifer A Unger, et al.
Plos Medicine|August 12, 2021
Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysisLukas E Brümmer, Stephan Katzenschlager, Mary Gaeddert, et al.
Plos Medicine|August 2, 2021
Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort studyAnnie Herbert, Meena Rafiq, Tra My Pham, et al.
Plos Medicine|August 5, 2021
Conflict-related intentional injuries in Baghdad, Iraq, 2003-2014: A modeling study and proposed method for calculating burden of injury in conflictGuy W Jensen, Riyadh Lafta, Gilbert Burnham, et al.
Plos Medicine|November 23, 2016
Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled TrialLara R Fairall, Naomi Folb, Venessa Timmerman, et al.
Plos Medicine|December 14, 2016
Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic AnalysisTingting Jiang, Weiwei Shi, Vikram B Wali, et al.
Plos Medicine|November 30, 2016
Towards Equity in Health: Researchers Take Stock, Annette Rid, Michael A Johansson, et al.
Plos Medicine|December 7, 2016
Sequencing Strategies to Guide Decision Making in Cancer TreatmentJames T Topham, Marco A Marra
Plos Medicine|October 19, 2016
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling StudyAlessandro Cassini, Diamantis Plachouras, Tim Eckmanns, et al.
Plos Medicine|October 12, 2016
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding TrialJohn A Todd, Marina Evangelou, Antony J Cutler, et al.
Pageof 404